VIJAYA Vijaya Diagnostic Centre Q2 FY26 results (Jul–Sep 2025) and concall
Vijaya Diagnostic Centre reported a healthy Q2 FY26 with consolidated revenue of Rs.202 crores, up 10.2% YoY, and a strong EBITDA margin of 40.6%. H1 FY26 revenue grew 15% YoY to INR390 crores with a 40% EBITDA margin. The company saw strong performance from new hub centers, with Yelahanka in Bengaluru achieving break-even ahead of schedule. While pathology growth was muted due to seasonal factors and a high base, radiology grew robustly at 16% YoY.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q2 FY26: revenue up 10.4%, net profit up 2.4% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|
| Revenue | 183 | 169 | 173 | 188 | 202 +10% |
| EBITDA | 76 | 67 | 69 | 74 | 82 +8% |
| Net profit | 42 | 35 | 35 | 39 | 43 +2% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
